Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,300 | 48 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $378.24 | 10 | $0 (2024) |
| PFIZER INC. | $285.98 | 15 | $0 (2024) |
| Allergan, Inc. | $184.06 | 5 | $0 (2020) |
| Abbott Laboratories | $164.27 | 7 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $139.69 | 3 | $0 (2018) |
| CSL Behring | $41.35 | 2 | $0 (2024) |
| ABIOMED | $27.98 | 1 | $0 (2024) |
| Gilead Sciences, Inc. | $25.65 | 1 | $0 (2023) |
| BioXcel Therapeutics, Inc. | $17.63 | 1 | $0 (2023) |
| Bolton Medical Inc | $16.83 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $185.89 | 10 | PFIZER INC. ($67.37) |
| 2023 | $444.26 | 12 | ABBVIE INC. ($283.36) |
| 2022 | $123.90 | 5 | PFIZER INC. ($63.88) |
| 2021 | $42.98 | 2 | AbbVie Inc. ($42.98) |
| 2020 | $102.05 | 4 | Allergan, Inc. ($45.81) |
| 2019 | $133.42 | 3 | Allergan Inc. ($119.53) |
| 2018 | $127.66 | 2 | E.R. Squibb & Sons, L.L.C. ($110.83) |
| 2017 | $140.10 | 10 | PFIZER INC. ($67.01) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $27.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2024 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 10/10/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/17/2024 | Abbott Laboratories | I-STAT (Device) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Point of Care | ||||||
| 08/05/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/28/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/05/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $4.97 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/24/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/06/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/28/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/06/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/12/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: COVID-19 | ||||||
| 10/09/2023 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 10/04/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $124.65 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/27/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $4.56 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/02/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/07/2023 | Abbott Laboratories | I-STAT (Device) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Point of Care | ||||||
| 05/17/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: NEUROSCIENCE | ||||||
| 04/13/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/12/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/07/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/10/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/12/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/02/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/16/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 278 | 279 | $105,014 | $31,696 |
| 2022 | 3 | 266 | 272 | $91,046 | $28,859 |
| 2021 | 3 | 111 | 111 | $37,317 | $12,331 |
| 2020 | 3 | 81 | 82 | $27,523 | $8,467 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 129 | 129 | $58,166 | $17,614 | 30.3% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 88 | 88 | $26,514 | $8,339 | 31.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 20 | 21 | $12,810 | $3,471 | 27.1% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 41 | 41 | $7,524 | $2,272 | 30.2% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 95 | 97 | $43,737 | $13,463 | 30.8% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 127 | 129 | $38,868 | $12,762 | 32.8% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 44 | 46 | $8,441 | $2,634 | 31.2% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 44 | 44 | $19,840 | $6,534 | 32.9% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 44 | 44 | $13,257 | $4,420 | 33.3% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 23 | 23 | $4,221 | $1,377 | 32.6% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 32 | 33 | $14,880 | $4,650 | 31.3% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 31 | 31 | $9,340 | $2,917 | 31.2% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 18 | 18 | $3,303 | $900.32 | 27.3% |
About Dr. Michael Klevens, M.D
Dr. Michael Klevens, M.D is a Emergency Medicine healthcare provider based in Chesterfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063445500.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Klevens, M.D has received a total of $1,300 in payments from pharmaceutical and medical device companies, with $185.89 received in 2024. These payments were reported across 48 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,300).
As a Medicare-enrolled provider, Klevens has provided services to 736 Medicare beneficiaries, totaling 744 services with total Medicare billing of $81,353. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Chesterfield, MO
- Active Since 07/08/2006
- Last Updated 04/22/2025
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1063445500
Products in Payments
- DALVANCE (Drug) $423.04
- ELIQUIS (Drug) $386.37
- BOTOX (Drug) $104.72
- ID NOW INSTRUMENT (Device) $60.02
- i-STAT CTnl (Device) $43.61
- Kcentra (Biological) $41.35
- CHANTIX (Drug) $39.30
- I-STAT (Device) $34.85
- TEFLARO (Drug) $34.54
- Impella (Device) $27.98
- Veklury (Drug) $25.65
- IGALMI (Drug) $17.63
- Relay Plus (Device) $16.83
- i-STAT CG4 (Device) $13.89
- Activase (Biological) $13.61
- i-STAT 1 (Device) $11.90
- LifeVest (Device) $4.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Chesterfield
Dr. William Gueck, M.d, M.D
Emergency Medicine — Payments: $651.62
Dr. Sonny Saggar, M.d, M.D
Emergency Medicine — Payments: $239.16
Dr. Daniel Schwartz, M.d, M.D
Emergency Medicine — Payments: $234.21
Matthew Kiblinger, Md, MD
Emergency Medicine — Payments: $187.65
Kellie Hughes, M.d, M.D
Emergency Medicine — Payments: $167.42
Milton Sallis, Md, MD
Emergency Medicine — Payments: $166.63